Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis; a Multicenter, Non-inferiority, Penta-blind, Randomized Trial

NCT02553473 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.

NCT NCT02553473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis; a Multicenter, Non-inferiority, Penta-blind, Randomized Trial
Lead sponsor
Sorlandet Hospital HF
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2015
Completion date
February 28, 2021
Enrollment
121 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuroborreliosis, borrelia burgdorferi